Profilaktika - Company finances
|
EUR
|
2021
From: 2021-10-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 484,525 | 669,209 | 770,971 | 806,097 |
| Profit before tax | - | - | 113,108 | 114,538 | 93,381 |
| Net profit | -606 | 91,246 | 95,841 | 97,105 | 78,323 |
| Equity | 1,894 | 93,140 | 98,982 | 106,086 | 94,409 |
| Liabilities | 0 | 33,843 | 40,959 | 47,498 | 28,008 |
| Non-current assets | 0 | 78,338 | 70,022 | 73,038 | 62,154 |
| Current assets | 1,536 | 47,488 | 85,709 | 108,922 | 91,586 |
| Total assets | 1,536 | 125,826 | 155,731 | 181,960 | 153,740 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 92,794 | 111,692 | 113,680 |
| Social insurance contributions | - | - | 72,020 | 92,169 | 99,986 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +38.1% | +15.2% | +4.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -39.5% | 72.5% | 61.5% | 53.4% | 50.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -32.0% | 98.0% | 96.8% | 91.5% | 83.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 18.8% | 14.3% | 12.6% | 9.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 16.9% | 14.9% | 11.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.4 | 0.4 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 51,914 | 40,764 | 43,847 | 47,651 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Profilaktika - Social security debts
The company had no debts to Sodra
Profilaktika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Profilaktika, UAB (code 305909703) is a private limited liability company engaged in general medical practice activities. In the latest financial year, 2025, the company generated revenue of €806.1K, up 4.6% year on year and 20.5% over two years. Net profit amounted to €78.3K, compared with €97.1K in 2024 and €95.8K in 2023, showing that profitability weakened even as turnover continued to rise. The net profit margin declined from 14.3% in 2023 to 12.6% in 2024 and 9.7% in 2025. On the balance sheet, total assets were €153.7K at the end of 2025, with equity of €94.4K and liabilities of €28.0K. Equity represented 61.4% of assets, and debt-to-equity stood at 0.30. Asset turnover was 5.24x, indicating efficient use of the asset base. Return on equity was 83.0% and return on assets 51.0%, supported by a relatively small equity and asset base. Revenue per employee reached €50.4K, while profit per employee was €4.9K.